209 related articles for article (PubMed ID: 20940393)
1. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis.
Wang H; Owens C; Chandra N; Conaway MR; Brautigan DL; Theodorescu D
Cancer Res; 2010 Nov; 70(21):8760-9. PubMed ID: 20940393
[TBL] [Abstract][Full Text] [Related]
2. RalBP1 is necessary for metastasis of human cancer cell lines.
Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
[TBL] [Abstract][Full Text] [Related]
3. RalA and RalB: antagonistic relatives in cancer cell migration.
Oxford G; Owens CR; Titus BJ; Foreman TL; Herlevsen MC; Smith SC; Theodorescu D
Cancer Res; 2005 Aug; 65(16):7111-20. PubMed ID: 16103060
[TBL] [Abstract][Full Text] [Related]
4. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
5. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
6. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
7. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
Smith SC; Baras AS; Owens CR; Dancik G; Theodorescu D
Cancer Res; 2012 Jul; 72(14):3480-91. PubMed ID: 22586063
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
Oxford G; Smith SC; Hampton G; Theodorescu D
Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
[TBL] [Abstract][Full Text] [Related]
10. Dissection of pathways implicated in integrin-mediated actin cytoskeleton assembly. Involvement of protein kinase C, Rho GTPase, and tyrosine phosphorylation.
Defilippi P; Venturino M; Gulino D; Duperray A; Boquet P; Fiorentini C; Volpe G; Palmieri M; Silengo L; Tarone G
J Biol Chem; 1997 Aug; 272(35):21726-34. PubMed ID: 9268301
[TBL] [Abstract][Full Text] [Related]
11. Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons.
Matsuoka Y; Li X; Bennett V
J Cell Biol; 1998 Jul; 142(2):485-97. PubMed ID: 9679146
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases.
Schmidt M; Voss M; Thiel M; Bauer B; Grannass A; Tapp E; Cool RH; de Gunzburg J; von Eichel-Streiber C; Jakobs KH
J Biol Chem; 1998 Mar; 273(13):7413-22. PubMed ID: 9516439
[TBL] [Abstract][Full Text] [Related]
13. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model.
Rybko VA; Knizhnik AV; Komelkov AV; Aushev VN; Trukhanova LS; Tchevkina EM
Cancer Cell Int; 2011 Jun; 11(1):22. PubMed ID: 21714887
[TBL] [Abstract][Full Text] [Related]
14. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
15. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.
Gentry LR; Nishimura A; Cox AD; Martin TD; Tsygankov D; Nishida M; Elston TC; Der CJ
J Biol Chem; 2015 Sep; 290(37):22851-61. PubMed ID: 26216878
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
[TBL] [Abstract][Full Text] [Related]
17. Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
Herlevsen MC; Theodorescu D
Biochem Biophys Res Commun; 2007 Oct; 362(1):56-62. PubMed ID: 17706599
[TBL] [Abstract][Full Text] [Related]
18. Small molecules inhibit the RAS-like small GTPases RALA and RALB.
Cancer Discov; 2014 Nov; 4(11):1251. PubMed ID: 25367937
[TBL] [Abstract][Full Text] [Related]
19. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
20. RalA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling.
Balasubramanian N; Meier JA; Scott DW; Norambuena A; White MA; Schwartz MA
Curr Biol; 2010 Jan; 20(1):75-9. PubMed ID: 20005108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
